May 14, 2014
Japanese ophthalmic powerhouse Santen Pharmaceutical will obtain the rights to US drug titan Merck & Co.’s nine ophthalmology products in Japan as well as other key markets in Europe and Asia Pacific, the two companies said on May 13. The...read more